Literature DB >> 15234351

Expression of the neurotrophin receptor trkB is regulated by the cAMP/CREB pathway in neurons.

Rubén Deogracias1, Gemma Espliguero, Teresa Iglesias, Angeles Rodríguez-Peña.   

Abstract

trkB as receptor for neurotrophins brain-derived neurotrophic factor (BDNF)/neurotrophin (NT)-4/5 plays a crucial role during development, maintenance of the adult brain, and its adaptation to injury or pathological conditions. In spite of this, very little is known about the mechanisms that regulate its expression. Here, we show that forskolin (Fk) rapidly stimulates the expression of both the full-length and truncated trkB isoforms in primary cultures of cortical neurons. Gel shift assays and transient transfection experiments demonstrate that this activation occurs via a protein kinase A (PKA)/cyclic AMP-responsive element-binding protein (CREB)-dependent mechanism. Activated CREB binds to the second cyclic AMP (cAMP)-responsive element (CRE) of the two CRE sites located within the P2 promoter of the trkB gene, which is able to confer cAMP responsiveness to a heterologous promoter. Our results illustrate that the trkB gene is a target for CREB regulation and explain the increase of trkB expression produced in different adaptative responses of the nervous system where CREB is participating. Copyright 2004 Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15234351     DOI: 10.1016/j.mcn.2004.03.007

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  30 in total

1.  Impaired TrkB-mediated ERK1/2 activation in huntington disease knock-in striatal cells involves reduced p52/p46 Shc expression.

Authors:  Silvia Ginés; Paola Paoletti; Jordi Alberch
Journal:  J Biol Chem       Date:  2010-05-04       Impact factor: 5.157

Review 2.  Role of electrical activity in promoting neural repair.

Authors:  Jeffrey L Goldberg
Journal:  Neurosci Lett       Date:  2012-02-10       Impact factor: 3.046

3.  Activation of NR2A receptors induces ischemic tolerance through CREB signaling.

Authors:  Yasukazu Terasaki; Tsutomu Sasaki; Yoshiki Yagita; Shuhei Okazaki; Yukio Sugiyama; Naoki Oyama; Emi Omura-Matsuoka; Saburo Sakoda; Kazuo Kitagawa
Journal:  J Cereb Blood Flow Metab       Date:  2010-02-10       Impact factor: 6.200

4.  Fndc5 knockdown significantly decreased the expression of neurotrophins and their respective receptors during neural differentiation of mouse embryonic stem cells.

Authors:  Reihane Ebadi; Farzaneh Rabiee; DorMohammad Kordi-Tamandani; Mohammad Hossein Nasr-Esfahani; Kamran Ghaedi
Journal:  Hum Cell       Date:  2021-03-08       Impact factor: 4.174

5.  Protein kinases A and C in post-mortem prefrontal cortex from persons with major depression and normal controls.

Authors:  Richard C Shelton; D Hal Manier; David A Lewis
Journal:  Int J Neuropsychopharmacol       Date:  2009-07-02       Impact factor: 5.176

6.  Dysregulation of TrkB phosphorylation and proBDNF protein in adenylyl cyclase 1 and 8 knockout mice in a model of fetal alcohol spectrum disorder.

Authors:  Laura L Susick; Alexandria C Chrumka; Steven M Hool; Alana C Conti
Journal:  Alcohol       Date:  2016-01-12       Impact factor: 2.405

7.  Modulation of the cAMP signaling pathway after traumatic brain injury.

Authors:  Coleen M Atkins; Anthony A Oliva; Ofelia F Alonso; Damien D Pearse; Helen M Bramlett; W Dalton Dietrich
Journal:  Exp Neurol       Date:  2007-08-29       Impact factor: 5.330

Review 8.  Neuroscience of alcoholism: molecular and cellular mechanisms.

Authors:  Sachin Moonat; Bela G Starkman; Amul Sakharkar; Subhash C Pandey
Journal:  Cell Mol Life Sci       Date:  2009-09-10       Impact factor: 9.261

Review 9.  The molecular neurobiology of depression.

Authors:  Richard C Shelton
Journal:  Psychiatr Clin North Am       Date:  2007-03

10.  Ca2+, CREB and krüppel: a novel KLF7-binding element conserved in mouse and human TRKB promoters is required for CREB-dependent transcription.

Authors:  Tami J Kingsbury; Bruce K Krueger
Journal:  Mol Cell Neurosci       Date:  2007-05-04       Impact factor: 4.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.